Skip to search formSkip to main contentSkip to account menu

oxepinac

Known as: 6,7-dihydro-11-oxodibenz(b,e)oxepin-3-acetic acid, dibenz(b,e)oxepin-3-acetic acid, 6,11-dihydro-11-oxo- 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AcetatesDibenzoxepins

Narrower (1)

DD-3314

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
Nonsteroidal antiinflammatory agents. V. Photolysis of 6,11-dihydro-11-oxodibenz[b,e]oxepin-3-acetic acid.
Photolysis of 6, 11-dihydro-11-oxodibenz [b, e] oxepin-3-acetic acid (1, oxepinac) in 1N NaOH solution by sunlight gave 3… 
1980
1980
Quantitative analysis of oxepinac in human plasma, urine and saliva by gas chromatography--mass fragmentography.
1978
1978
Multi-centered clinical evaluation of oxepinac against peripheral arthropathy particularly osteoarthritis.
Clinical evaluation in phase II of 6,11-dihydro-11-oxodibenz[b,e]oxepin-3-acetic acid (oxepinac) has been made in a single-blind… 
1978
1978
General pharmacology of oxepinac.
1978
1978
Studies on pharmacokinetics and biotransformation of oxepinac in mouse, rat, dog and man.
1978
1978
Teratogenicity study of oxepinac in mice and rabbits.
Teratogenic effects of 6,11-dihydro-11-oxodibenz[b,e]oxepin-3-acetic acid (oxepinac) were examined in mice and rabbits. Oxepinac… 
1978
1978
Acute, subacute and chronic toxicity of oxepinac.
The acute, subacute and chronic toxicity of 6,11-dihydro-11-oxodibenz[b,e]oxepin-3-acetic acid (oxepinac) was investigated in… 
1978
1978
CHRONIC TOXICITY OF OXEPINAC (DD-3314), A NEW ANTIINFLAMMATORY DRUG IN BEAGLE DOGS (The 5th Meeting for the Study of Toxic Effect)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)